Number of employees
78
Annual revenue
$3854000
Develops and manufactures diagnostic and drug delivery systems, primarily a painless, bloodless and automatic glucose monitoring device and transdermal drug delivery systems which provide for controlled release of drugs directly into the bloodstream through intact skin. (Nasdaq: CYGN).